Effects of longevinex (modified resveratrol) on cardioprotection and its mechanisms of action

Subhendu Mukherjee, Diptarka Ray, I. Lekli, I. Bak, A. Tósaki, Dipak K. Das

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Although resveratrol has been proven to possess diverse health benefits, several recent reports have demon-strated conflicting results on some aspects of its effects, including its anti-aging properties. Considerable debate appears to exist on the dose and bioavailability of resveratrol, leading to the controversies on its effectiveness. To resolve the problem, we designed a study with a resveratrol formulation that contained resveratrol supplemented with 5% quercetin and 5% rice bran phytate (commercially known as Longevinex). These ingredients were micronized to increase the bioavailability. Sprague-Dawley rats were gavaged with either Longevinex or vehicle (5% quercetin plus 5% rice bran phytate), and rats were sacrificed after 1 or 3 months, when isolated working hearts were subjected to 30 min ischemia followed by 2hofreperfusion. Longevinex-treated hearts, irrespective oftheduration oftreatments, revealed superiorcardiac performance, reduced infarct size, and induction of survival signals as evidenced by increased Bcl2/Bax ratio and enhanced Akt phosphorylation. In contrast, LC3-II and Beclin were enhanced significantly after 3 months of Longevinex treatment, suggesting that autophagy occurred only after feeding Longevinex to rats for a prolonged period of time. Corroborating with the results of autophagy, Sirt1 and Sirt3 increased significantly only after 3 months of Longevinex treatment, suggesting that enhanced expression of Sirts correlated with induction of autophagy. In concert, Longevinex caused phosphorylation and nuclear translocation of FoxO1, FoxO3a, and FoxO4, indicating involvement of FoxOs with autophagy. Since Sirts and FoxOs are reliable markers of longevity, the results appear to suggest that Longevinex induces longevity after prolonged feeding via induction of autophagy, while it converts death signals into survival signals and provides cardioprotection within a relatively shorter period of time.

Original languageEnglish
Pages (from-to)1017-1025
Number of pages9
JournalCanadian Journal of Physiology and Pharmacology
Volume88
Issue number11
DOIs
Publication statusPublished - Nov 2010

Fingerprint

Autophagy
rats
bioavailability
induction
phosphorylation
rice
Phytic Acid
Quercetin
ischemia
Biological Availability
death
ingredients
markers
health
Phosphorylation
vehicles
formulations
Insurance Benefits
dosage
Sprague Dawley Rats

Keywords

  • Autophagy
  • Cardioprotection
  • Longevinex
  • Longevity
  • Resveratrol
  • Survival signal

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Pharmacology
  • Physics and Astronomy(all)

Cite this

Effects of longevinex (modified resveratrol) on cardioprotection and its mechanisms of action. / Mukherjee, Subhendu; Ray, Diptarka; Lekli, I.; Bak, I.; Tósaki, A.; Das, Dipak K.

In: Canadian Journal of Physiology and Pharmacology, Vol. 88, No. 11, 11.2010, p. 1017-1025.

Research output: Contribution to journalArticle

@article{67d2059d28cb49168651f46687b70e16,
title = "Effects of longevinex (modified resveratrol) on cardioprotection and its mechanisms of action",
abstract = "Although resveratrol has been proven to possess diverse health benefits, several recent reports have demon-strated conflicting results on some aspects of its effects, including its anti-aging properties. Considerable debate appears to exist on the dose and bioavailability of resveratrol, leading to the controversies on its effectiveness. To resolve the problem, we designed a study with a resveratrol formulation that contained resveratrol supplemented with 5{\%} quercetin and 5{\%} rice bran phytate (commercially known as Longevinex). These ingredients were micronized to increase the bioavailability. Sprague-Dawley rats were gavaged with either Longevinex or vehicle (5{\%} quercetin plus 5{\%} rice bran phytate), and rats were sacrificed after 1 or 3 months, when isolated working hearts were subjected to 30 min ischemia followed by 2hofreperfusion. Longevinex-treated hearts, irrespective oftheduration oftreatments, revealed superiorcardiac performance, reduced infarct size, and induction of survival signals as evidenced by increased Bcl2/Bax ratio and enhanced Akt phosphorylation. In contrast, LC3-II and Beclin were enhanced significantly after 3 months of Longevinex treatment, suggesting that autophagy occurred only after feeding Longevinex to rats for a prolonged period of time. Corroborating with the results of autophagy, Sirt1 and Sirt3 increased significantly only after 3 months of Longevinex treatment, suggesting that enhanced expression of Sirts correlated with induction of autophagy. In concert, Longevinex caused phosphorylation and nuclear translocation of FoxO1, FoxO3a, and FoxO4, indicating involvement of FoxOs with autophagy. Since Sirts and FoxOs are reliable markers of longevity, the results appear to suggest that Longevinex induces longevity after prolonged feeding via induction of autophagy, while it converts death signals into survival signals and provides cardioprotection within a relatively shorter period of time.",
keywords = "Autophagy, Cardioprotection, Longevinex, Longevity, Resveratrol, Survival signal",
author = "Subhendu Mukherjee and Diptarka Ray and I. Lekli and I. Bak and A. T{\'o}saki and Das, {Dipak K.}",
year = "2010",
month = "11",
doi = "10.1139/Y10-082",
language = "English",
volume = "88",
pages = "1017--1025",
journal = "Canadian Journal of Physiology and Pharmacology",
issn = "0008-4212",
publisher = "National Research Council of Canada",
number = "11",

}

TY - JOUR

T1 - Effects of longevinex (modified resveratrol) on cardioprotection and its mechanisms of action

AU - Mukherjee, Subhendu

AU - Ray, Diptarka

AU - Lekli, I.

AU - Bak, I.

AU - Tósaki, A.

AU - Das, Dipak K.

PY - 2010/11

Y1 - 2010/11

N2 - Although resveratrol has been proven to possess diverse health benefits, several recent reports have demon-strated conflicting results on some aspects of its effects, including its anti-aging properties. Considerable debate appears to exist on the dose and bioavailability of resveratrol, leading to the controversies on its effectiveness. To resolve the problem, we designed a study with a resveratrol formulation that contained resveratrol supplemented with 5% quercetin and 5% rice bran phytate (commercially known as Longevinex). These ingredients were micronized to increase the bioavailability. Sprague-Dawley rats were gavaged with either Longevinex or vehicle (5% quercetin plus 5% rice bran phytate), and rats were sacrificed after 1 or 3 months, when isolated working hearts were subjected to 30 min ischemia followed by 2hofreperfusion. Longevinex-treated hearts, irrespective oftheduration oftreatments, revealed superiorcardiac performance, reduced infarct size, and induction of survival signals as evidenced by increased Bcl2/Bax ratio and enhanced Akt phosphorylation. In contrast, LC3-II and Beclin were enhanced significantly after 3 months of Longevinex treatment, suggesting that autophagy occurred only after feeding Longevinex to rats for a prolonged period of time. Corroborating with the results of autophagy, Sirt1 and Sirt3 increased significantly only after 3 months of Longevinex treatment, suggesting that enhanced expression of Sirts correlated with induction of autophagy. In concert, Longevinex caused phosphorylation and nuclear translocation of FoxO1, FoxO3a, and FoxO4, indicating involvement of FoxOs with autophagy. Since Sirts and FoxOs are reliable markers of longevity, the results appear to suggest that Longevinex induces longevity after prolonged feeding via induction of autophagy, while it converts death signals into survival signals and provides cardioprotection within a relatively shorter period of time.

AB - Although resveratrol has been proven to possess diverse health benefits, several recent reports have demon-strated conflicting results on some aspects of its effects, including its anti-aging properties. Considerable debate appears to exist on the dose and bioavailability of resveratrol, leading to the controversies on its effectiveness. To resolve the problem, we designed a study with a resveratrol formulation that contained resveratrol supplemented with 5% quercetin and 5% rice bran phytate (commercially known as Longevinex). These ingredients were micronized to increase the bioavailability. Sprague-Dawley rats were gavaged with either Longevinex or vehicle (5% quercetin plus 5% rice bran phytate), and rats were sacrificed after 1 or 3 months, when isolated working hearts were subjected to 30 min ischemia followed by 2hofreperfusion. Longevinex-treated hearts, irrespective oftheduration oftreatments, revealed superiorcardiac performance, reduced infarct size, and induction of survival signals as evidenced by increased Bcl2/Bax ratio and enhanced Akt phosphorylation. In contrast, LC3-II and Beclin were enhanced significantly after 3 months of Longevinex treatment, suggesting that autophagy occurred only after feeding Longevinex to rats for a prolonged period of time. Corroborating with the results of autophagy, Sirt1 and Sirt3 increased significantly only after 3 months of Longevinex treatment, suggesting that enhanced expression of Sirts correlated with induction of autophagy. In concert, Longevinex caused phosphorylation and nuclear translocation of FoxO1, FoxO3a, and FoxO4, indicating involvement of FoxOs with autophagy. Since Sirts and FoxOs are reliable markers of longevity, the results appear to suggest that Longevinex induces longevity after prolonged feeding via induction of autophagy, while it converts death signals into survival signals and provides cardioprotection within a relatively shorter period of time.

KW - Autophagy

KW - Cardioprotection

KW - Longevinex

KW - Longevity

KW - Resveratrol

KW - Survival signal

UR - http://www.scopus.com/inward/record.url?scp=78549272759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78549272759&partnerID=8YFLogxK

U2 - 10.1139/Y10-082

DO - 10.1139/Y10-082

M3 - Article

VL - 88

SP - 1017

EP - 1025

JO - Canadian Journal of Physiology and Pharmacology

JF - Canadian Journal of Physiology and Pharmacology

SN - 0008-4212

IS - 11

ER -